GlassScriptPhysician profile
Roxann M Brown
NPI 1679861520
$2,947.79
in general payments reported to CMS, 2019-2025
19 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $670 · 2022: $584 · 2023: $730 · 2024: $563 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $518.53 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $457.79 | 2021-2024 | Caplyta |
| Lundbeck LLC | $395.40 | 2021-2025 | Rexulti |
| Alkermes, INC. | $388.27 | 2021-2025 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $260.27 | 2022-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $242.52 | 2021-2025 | Trintellix |
| Sunovion Pharmaceuticals INC. | $207.05 | 2021-2022 | |
| Axsome Therapeutics, INC. | $94.43 | 2023-2025 | Auvelity |
| Merck Sharp & Dohme LLC | $84.15 | 2021-2023 | Belsomra |
| Otsuka America Pharmaceutical, INC. | $79.20 | 2021-2025 | Rexulti |
| Collegium Pharmaceutical, INC. | $40.62 | 2025 | Jornay Pm |
| Neurocrine Biosciences, INC. | $32.75 | 2023-2025 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $29.75 | 2025 | Cobenfy |
| Sage Therapeutics, LLC | $29.65 | 2024 | |
| Alexion Pharmaceuticals, INC. | $22.61 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $20.55 | 2021 | |
| Amgen INC. | $18.50 | 2022 | |
| Jazz Pharmaceuticals INC. | $13.41 | 2022 | |
| Allergan, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxann Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.